117 related articles for article (PubMed ID: 38548408)
21. Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
Ratta M; Curti A; Fogli M; Pantucci M; Viscomi G; Tazzari P; Fagnoni F; Vescovini R; Sansoni P; Tura S; Lemoli RM
Exp Hematol; 2000 Aug; 28(8):931-40. PubMed ID: 10989194
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy of malignant melanoma with tumor lysate-pulsed autologous monocyte-derived dendritic cells.
Kim DS; Kim DH; Goo B; Cho YH; Park JM; Lee TH; Kim HO; Kim HS; Lee H; Lee JD; Byamba D; Je JH; Lee MG
Yonsei Med J; 2011 Nov; 52(6):990-8. PubMed ID: 22028165
[TBL] [Abstract][Full Text] [Related]
23. The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors.
Kuppner MC; Gastpar R; Gelwer S; Nössner E; Ochmann O; Scharner A; Issels RD
Eur J Immunol; 2001 May; 31(5):1602-9. PubMed ID: 11465118
[TBL] [Abstract][Full Text] [Related]
24. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
25. A novel, rapid strategy to form dendritomas from human dendritic cells and hepatocellular carcinoma cell line HCCLM3 cells using mature dendritic cells derived from human peripheral blood CD14+ monocytes within 48 hours of in vitro culture.
Guan X; Peng JR; Yuan L; Wang H; Wei YH; Leng XS
World J Gastroenterol; 2004 Dec; 10(24):3564-8. PubMed ID: 15534907
[TBL] [Abstract][Full Text] [Related]
26. Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care.
Bapsy PP; Sharan B; Kumar C; Das RP; Rangarajan B; Jain M; Suresh Attili VS; Subramanian S; Aggarwal S; Srivastava M; Vaid A
Cytotherapy; 2014 Feb; 16(2):234-44. PubMed ID: 24438902
[TBL] [Abstract][Full Text] [Related]
27. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.
Inogés S; Tejada S; de Cerio AL; Gállego Pérez-Larraya J; Espinós J; Idoate MA; Domínguez PD; de Eulate RG; Aristu J; Bendandi M; Pastor F; Alonso M; Andreu E; Cardoso FP; Valle RD
J Transl Med; 2017 May; 15(1):104. PubMed ID: 28499389
[TBL] [Abstract][Full Text] [Related]
28. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.
Tang J; Flomenberg P; Harshyne L; Kenyon L; Andrews DW
Clin Cancer Res; 2005 Jul; 11(14):5292-9. PubMed ID: 16033848
[TBL] [Abstract][Full Text] [Related]
29. Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99.
Kim YH; Tran TA; Lee HJ; Jung SI; Lee JJ; Jang WY; Moon KS; Kim IY; Jung S; Jung TY
Oncotarget; 2016 Aug; 7(31):50535-50547. PubMed ID: 27409668
[TBL] [Abstract][Full Text] [Related]
30. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
31. [Effects of Dasatinib on the Maturation of Monocyte-Derived Dendritic Cells Derived from Healthy Donors and Chronic Myelogenous Leukemia Patients].
Cao WJ; Dai JY; Dong WJ; Wang X; Wang XD; Xia JY; Li XH; Zhou H; Chen J; He L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):677-687. PubMed ID: 35680790
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells primed with HPV positive cervical tumor lysate are superior to unprimed DCs in migratory capacity and induce a potent Th1 response.
Ramanathan P; Dhandapani H; Jayakumar H; Ganeshrajah S; Thangarajan R
Hum Immunol; 2014 Dec; 75(12):1216-24. PubMed ID: 25315748
[TBL] [Abstract][Full Text] [Related]
33. [Expression of CC-chemokine ligand 18 (CCL18) in the serum and pleural effusion of non-small-cell lung cancer patients and its regulatory effect on the differentiation of monocyte-derived dendritic cells].
Chen L; Zhou Q; Zhong F; Wang Q; Fang Y; Yang K; Guan S
Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):823-7. PubMed ID: 25620478
[TBL] [Abstract][Full Text] [Related]
34. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes.
Canning MO; Grotenhuis K; de Wit H; Ruwhof C; Drexhage HA
Eur J Endocrinol; 2001 Sep; 145(3):351-7. PubMed ID: 11517017
[TBL] [Abstract][Full Text] [Related]
35. Generation of functional and mature dendritic cells from cord blood and bone marrow CD34+ cells by two-step culture combined with calcium ionophore treatment.
Liu A; Takahashi M; Narita M; Zheng Z; Kanazawa N; Abe T; Nikkuni K; Furukawa T; Toba K; Fuse I; Aizawa Y
J Immunol Methods; 2002 Mar; 261(1-2):49-63. PubMed ID: 11861065
[TBL] [Abstract][Full Text] [Related]
36. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
37. Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.
Oosterwijk-Wakka JC; Tiemessen DM; Bleumer I; de Vries IJ; Jongmans W; Adema GJ; Debruyne FM; de Mulder PH; Oosterwijk E; Mulders PF
J Immunother; 2002; 25(6):500-8. PubMed ID: 12439347
[TBL] [Abstract][Full Text] [Related]
38. Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines.
Uslu U; Erdmann M; Wiesinger M; Schuler G; Schuler-Thurner B
Cytotherapy; 2019 Nov; 21(11):1166-1178. PubMed ID: 31668486
[TBL] [Abstract][Full Text] [Related]
39. Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC.
Martinson J; Bae J; Klingemann HG; Tam Y
Cytotherapy; 2004; 6(5):487-97. PubMed ID: 15512915
[TBL] [Abstract][Full Text] [Related]
40. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
